The Amyloidosis Channel is supported with funding from Prothena (Silver).
The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
VJVirtual | Bone marrow biopsy in patients with plasma cell disorders
Angela Dispenzieri, MD, of the Mayo Clinic College of Medicine, Rochester, MN, discusses the prognostic value of bone marrow biopsies in patients with plasma cell disorders, as well as its use of minimal residual disease measurement. This interview was recorded via an online conference call with the Video Journal of Hematological Oncology (VJHemOnc).
